Zobrazeno 1 - 10
of 22
pro vyhledávání: '"P. O. Rumiantsev"'
Autor:
P. A. Nikiforovich, P. O. Rumiantsev, I. V. Sleptsov, T. V. Ustinova, K. Yu. Slashchuk, S. L. Vorobyev, S. S. Serzhenko, A. Yu. Abrosimov, A. V. Kudryavtseva, A. A. Semenov, R. A. Chernikov, A. A. Polyakov, A. A. Fedenko, L. V. Bolotina, A. A. Paychadze, A. Y. Trushin, A. D. Kaprin, G. S. Zakharova
Publikováno v:
Сибирский онкологический журнал, Vol 19, Iss 5, Pp 131-144 (2020)
Anaplastic thyroid cancer is one of the most aggressive and fatal human carcinomas. A significant experience in using various kinase inhibitors for anaplastic thyroid cancer therapy has been accumulated worldwide. The most encouraging results were ob
Externí odkaz:
https://doaj.org/article/ec6e4b85a5e14e43b17b32835f976c57
ADJUVANT TREATMENT WITH BIPHOSPONATES IN COMPLEX THERAPY OF PAPILLARY THYROID CANCER BONE METASTASES
Autor:
A. D. Kaprin, A. P. Polyakov, P. O. Rumiantsev, K. S. Nizegorodova, M. V. Degtiarev, P. A. Nikiforovich, M. V. Ratushnyy, O. V. Matorin, M. M. Filushin, I. V. Rebrikova, A. L. Sugaipov, A. V. Mordovskiy
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 4, Iss 3, Pp 93-99 (2017)
Distant metastasis of thyroid cancer are founded in 10% of all metastases. Bone metastases are founded in 23% of distant metastasis. Complications associated with metastatic skeletal involvement often lead to a deterioration in the overall condition
Externí odkaz:
https://doaj.org/article/64180425671344609b491c0776de3faf
Autor:
P. A. Isaev, D. Y. Siomin, P. O. Rumiantsev, V. V. Polkin, A. A. Ilyin, N. Y. Dvinskyh, V. S. Medvedev
Publikováno v:
Эндокринная хирургия, Vol 9, Iss 4, Pp 22-25 (2015)
Thyrolipomas are rare benign neoplasms composed of mature adipose tissue and glandular elements. The most common clinical manifestation is a slowly enlarging neck mass. If thyroid fine-needle aspiration biopsy discloses a mixed population of adipocyt
Externí odkaz:
https://doaj.org/article/94af7a2090014953bc379c77f2c68f1a
Autor:
Pavel V. Sviridov, Pavel O. Rumiantsev, Mikhail V. Degtyarev, Sergey S. Serzhenko, Dmitry B. Sanin, Sergey V. Styrov, Dmitry Yu. Agibalov, Sergey V. Korenev
Publikováno v:
Digital Diagnostics, Vol 4, Iss 3, Pp 411-426 (2023)
Brachytherapy with implantation of micro sources based on isotope 125I is a preferred treatment for localized prostate cancer without signs of germination of the gland capsule and in the absence of signs of metastases (stage cT1-T23aN0M0). Structural
Externí odkaz:
https://doaj.org/article/631cc935af304b8f8fa4cfb7506aaeed
Publikováno v:
Digital Diagnostics, Vol 3, Iss 4, Pp 404-412 (2023)
A modern multidisciplinary clinic is not only a medical facility, but also an engineering and often biotechnical facility. The technological complexity of the object depends on the planned (bio) medical profiles and functionality, the need for scalab
Externí odkaz:
https://doaj.org/article/91d473d5b324498c95bf182136779da6
Publikováno v:
Voprosy onkologii. 54(3)
Publikováno v:
Vestnik otorinolaringologii. (1)
Autor:
P O, Rumiantsev, D V, Zaletaev, E V, Vasil'ev, V A, Saenko, A A, Il'in, U V, Rumiantseva, A Iu, Abrosimov, V S, Medvedev
Publikováno v:
Voprosy onkologii. 52(2)
Frequency of RET/PTC rearrangement and somatic BRAF mutation was investigated in patients with papillary thyroid cancer (PTC) vis-a-vis relevant demographic and clinico-pathological features. The study group included 76 patients with a female/male ra
Autor:
N V, Severskaia, V A, Saenko, A A, Il'in, I V, Chebotareva, P O, Rumiantsev, P A, Isaev, V S, Medvedev, S, Iasmita
Publikováno v:
Molekuliarnaia biologiia. 40(3)
The role of RET and GFRA1 germline polymorphisms in predisposition to sporadic medullary thyroid cancer (MTC) and polymorphisms' modulation effect on clinical features of inherited and sporadic MTC were investigated. Blood samples from 67 MTC patient
Autor:
E V, Vasil'ev, P O, Rumiantsev, V A, Saenko, A A, Il'in, E Iu, Poliakova, M V, Nemtsova, D V, Zaletaev
Publikováno v:
Molekuliarnaia biologiia. 38(4)
Rearrangements of the RET proto-oncogene (RET/PTC) and BRAF gene mutations are the major genetic alterations in the etiopathogenesis of papillary thyroid carcinoma (PTC). We have analyzed a series of 118 benign and malignant follicular cell-derived t